Allarity Therapeutics (ALLR) Financials: Revenue & Earnings
ALLR$0.920.00 0.00%
$14.64M
Market Cap
—
P/E
—
Forward P/E
—
Score
Allarity Therapeutics (ALLR) Financials: Revenue & Earnings
ALLR price $0.92 0.00 0.00%
- Ticker
- ALLR
- Price
- $0.92
- Change
- 0.00 0.00%
- Market cap ?
- $14.64M
- Beta ?
- 0.57
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
ALLR fair value Not meaningful. Price $0.92.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-13 | — | -0.21 | — | — |
| 2026-08-14 | -0.21 | -0.25 | — | — |
| 2026-05-15 | -0.17 | -0.22 | 25.00K | 25.00K |
| 2026-03-31 | -0.19 | -0.22 | 320.00K | 320.00K |
| 2025-11-14 | -0.19 | -0.23 | — | — |
| 2025-08-15 | -0.15 | -0.21 | — | — |
| 2025-05-09 | -0.25 | — | — | — |
| 2025-04-04 | -4.73 | -8.10 | 6.00K | — |
| 2024-11-14 | -7.71 | -8.52 | — | — |
| 2024-08-05 | -3.30 | -0.29 | — | — |
| 2024-05-14 | -664.86 | -1.76 | — | — |
| 2024-03-08 | -0.43 | -0.25 | — | — |
| 2023-11-14 | -1,345.35 | -8.17 | — | — |
| 2023-08-14 | -15,783.78 | -11.19 | — | — |
| 2023-05-11 | -106,426.41 | -7.88 | — | — |
| 2023-03-13 | -0.23 | -0.42 | — | — |
| 2022-11-14 | -16,320.00 | -0.26 | — | — |
| 2022-10-07 | -604,800.56 | — | — | — |
| 2022-08-21 | -0.52 | -0.42 | — | — |
| 2022-05-17 | -2,143,780.88 | — | — | — |
| 2021-11-23 | 181,151.96 | — | — | — |
| 2021-06-30 | -1,388,344.70 | — | — | — |
| 2021-03-31 | -793,744.14 | — | — | — |
| 2020-12-31 | -30,617.68 | — | — | — |
| 2020-09-30 | -385,422.60 | — | — | — |
| 2019-12-31 | -3,714,656.67 | — | 357.58K | — |
| 2015-09-30 | -0.04 | — | 53.16K | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-30 | Graff Jeremy R. | Sell | 39.49K | — | — |
| 2026-09-30 | Graff Jeremy R. | Buy | 39.49K | — | — |
| 2026-09-30 | Graff Jeremy R. | Sell | 14.61K | $0.97 | 14.17K |
| 2026-01-28 | Jensen Thomas | Buy | 200.00K | — | — |
| 2026-01-28 | McLaughlin Gerald W. | Buy | 45.00K | — | — |
| 2026-01-28 | Graff Jeremy R. | Buy | 133.33K | — | — |
| 2026-01-28 | Ervin Jeffrey S | Buy | 150.00K | — | — |
| 2026-01-22 | Graff Jeremy R. | Sell | 48.15K | — | — |
| 2026-01-22 | Graff Jeremy R. | Buy | 48.15K | — | — |
| 2026-01-22 | Graff Jeremy R. | Sell | 17.81K | $1.18 | 21.02K |
| 2026-01-07 | Hoeiland Jesper | Buy | 25.00K | — | — |
| 2026-01-07 | Graff Jeremy R. | Buy | 133.33K | — | — |
| 2025-09-30 | Graff Jeremy R. | Sell | 39.49K | — | — |
| 2025-09-30 | Graff Jeremy R. | Buy | 39.49K | — | — |
| 2025-09-30 | Graff Jeremy R. | Sell | 14.61K | $1.58 | 23.09K |
| 2025-07-01 | Ervin Jeffrey S | Other | 0 | — | — |
| 2025-06-10 | Hoeiland Jesper | Other | 0 | — | — |
| 2025-01-22 | Graff Jeremy R. | Buy | 144.44K | — | — |
| 2025-01-22 | Epshinsky Alexander | Buy | 29.50K | — | — |
| 2025-01-22 | Jensen Thomas | Buy | 396.73K | — | — |
| 2025-01-22 | McLaughlin Gerald W. | Buy | 25.00K | $1.01 | 25.25K |
| 2025-01-22 | Vazzano Joseph Walter | Buy | 25.00K | $1.01 | 25.25K |
| 2025-01-22 | Benjamin Laura | Buy | 25.00K | $1.01 | 25.25K |
| 2024-09-30 | Graff Jeremy R. | Buy | 118.48K | $2.11 | 250.00K |
| 2024-09-30 | Graff Jeremy R. | Other | 0 | — | — |
| 2024-09-12 | Epshinsky Alexander | Sell | 0 | — | — |
| 2023-08-01 | Benjamin Laura | Other | 0 | — | — |
| 2023-08-01 | Vazzano Joseph Walter | Other | 0 | — | — |
| 2022-07-07 | Roth David | Other | 23.00K | $1.28 | 29.44K |
| 2022-06-29 | Brown Joan Yvonne | Other | 0 | — | — |
| 2022-06-27 | Knudsen Jens Erik | Other | 0 | — | — |
| 2021-12-20 | Jensen Thomas | Other | 0 | — | — |
| 2021-12-20 | Jensen Thomas | Other | 161.52K | $5.16 | 833.42K |
| 2021-12-20 | Sass Leon | Other | 0 | — | — |
| 2021-12-20 | Sass Leon | Other | 0 | — | — |
| 2021-12-20 | Knudsen Steen | Other | 0 | — | — |
| 2021-12-20 | Knudsen Steen | Other | 0 | — | — |
| 2021-12-20 | Knudsen Steen | Other | 78.33K | $5.16 | 404.21K |
| 2021-12-20 | Carchedi Steve | Other | 252.56K | $5.16 | 1.30M |
| 2021-12-20 | Carchedi Steve | Sell | 252.56K | $5.16 | 1.30M |
| 2021-12-20 | Carchedi Steve | Sell | 156.03K | $8.70 | 1.36M |
| 2021-12-20 | Carchedi Steve | Sell | 70.48K | $12.02 | 847.13K |
| 2021-12-20 | Carchedi Steve | Other | 70.48K | $12.02 | 847.13K |
| 2021-12-20 | Carchedi Steve | Other | 156.03K | $8.70 | 1.36M |
| 2021-12-20 | Jensen Soren Gade | Other | 0 | — | — |
| 2021-12-20 | Jensen Soren Gade | Other | 25.84K | $10.11 | 261.26K |
| 2021-12-20 | Jensen Soren Gade | Other | 400 | $8.69 | 3.48K |
| 2021-12-20 | Foegh Marie | Other | 0 | — | — |
| 2021-12-20 | Foegh Marie | Other | 78.33K | $5.16 | 404.21K |
| 2021-12-20 | Knudsen Jens Erik | Other | 39.60K | $7.70 | 304.92K |
| 2021-12-20 | Knudsen Jens Erik | Other | 22.58K | $5.16 | 116.53K |
| 2021-12-20 | Knudsen Jens Erik | Other | 18.57K | $10.50 | 195.03K |
| 2021-12-20 | Cullem James G. | Other | 28.19K | $13.22 | 372.69K |
| 2021-12-20 | Cullem James G. | Other | 133.32K | $5.16 | 687.96K |
| 2021-12-20 | Maderis Gail J | Sell | 400 | $8.69 | 3.48K |
| 2021-12-20 | Maderis Gail J | Sell | 25.84K | $10.11 | 261.26K |
| 2021-12-20 | Maderis Gail J | Other | 400 | $8.69 | 3.48K |
| 2021-12-20 | Maderis Gail J | Other | 25.84K | $10.11 | 261.26K |
| 2021-12-20 | Moore Duncan | Other | 0 | — | — |
| 2021-12-20 | Moore Duncan | Other | 41.99K | $10.11 | 424.56K |
Institutional holders
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| No data yet. | ||||
Earnings and financials
Allarity Therapeutics, Inc. (ALLR) trades at $0.92, with a market cap of $14.64M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn